iCoreConnect 10-Q/A 15 Nov 21 2021 Q2 Quarterly report (amended) Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2021	Nov. 15, 2021
Cover [Abstract]
Entity Registrant Name	iCoreConnect Inc.
Entity Central Index Key	0001408057
Document Type	10-Q/A
Amendment Flag	true
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		159,205,016
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity File Number	000-52765
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	13-4182867
Entity Address Address Line 1	13506 Summerport Village Pkwy #160
Entity Address City Or Town	Windermere
Entity Address State Or Province	FL
Entity Address Postal Zip Code	34786
City Area Code	888
Local Phone Number	810-7706
Security 12b Title	Common Stock, $.001 par value
Trading Symbol	ICCT
Amendment Description	This Amendment No. 1 (“Amendment No. 1”) to Form 10-Q/A amends the Form 10- Q of iCoreConnect Inc for the three months ended June 30, 2021 as filed with the Securities and Exchange Commission (the “SEC”) on August 23, 2021 (the “Original Filing”). As of June 30, 2021, we inadvertently considered these notes as promissory notes instead of properly classifying them as convertible notes. As result we failed to record a derivative liability of $ 1,281,176 due to the conversion features on the Notes. We are filing this Amendment No. 1 to restate our financial statements as of June 30, 2021 that were previously reported on the Original Filing. The following items have been amended to reflect the restatements:

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 846,039		$ 7,619
Accounts receivable, net	233,915		126,472
Prepaid expenses and other current assets	132,019		20,103
Total current assets	1,211,973		154,194
Property and equipment, net	15,090		2,405
Right of use lease asset - operating	118,182		150,477
Software development costs, net	698,349		768,907
Acquired technology, net	517,929		753,794
Customer relationships, net	1,855,664		369,524
Goodwill	1,291,109		491,376
Total long-term assets	4,496,323		2,536,483
TOTAL ASSETS	5,708,296		2,690,677
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable and accrued expenses	833,416		1,664,125
Operating lease liability, current portion	47,035		89,088
Notes payable	2,372,271		1,429,207
Deferred revenue, current portion	31,586		2,775
Total current liabilities	3,284,308		3,185,195
Operating lease liability, net of current portion	53,699		61,389
Deferred revenue, net of current portion	20,743		73,033
Total long-term liabilities	74,442		134,422
TOTAL LIABILITIES	3,358,750		3,319,617
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 151,613,399 as of June 30, 2021 and 90,081,336 as of December 31, 2020	151,613		90,081
Additional paid-in-capital	82,425,161		77,112,060
Accumulated deficit	(80,227,228)		(77,831,081)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	2,349,546	$ 576,178	(628,940)	$ 205,000	$ 553,000	$ 465,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 5,708,296		$ 2,690,677

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
STOCKHOLDERS' EQUITY
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	151,613,399	90,081,336
Common stock, shares Outstanding	151,613,399	90,081,336

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Revenue	$ 981,378	$ 472,000	$ 1,685,379	$ 978,000
Cost of sales	267,728	210,000	507,761	429,000
Gross profit	713,650	262,000	1,177,618	549,000
Expenses
Selling, general and administrative	1,003,870	870,000	1,860,258	1,679,000
Depreciation and amortization	250,715	225,000	503,412	448,000
Total operating expenses	1,254,585	1,095,000	2,363,670	2,127,000
Loss from operations	(540,935)	(833,000)	(1,186,052)	(1,578,000)
Other income (expense):
Interest expense	(92,526)	(34,000)	(260,323)	(69,000)
Other income (expense)	0	10,000	0	10,000
Loss on derivative liability	(1,281,176)	0	(1,281,176)	0
Gain on cancellation of liabilities	331,404	0	331,404	0
Total other income (expense)	(1,042,298)	(24,000)	(1,210,095)	(59,000)
Net loss	$ (1,583,233)	$ (857,000)	$ (2,396,147)	$ (1,637,000)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance, shares at Dec. 31, 2019		67,476,089
Balance, amount at Dec. 31, 2019	$ 465,000	$ 67,000	$ 74,738,000	$ (74,340,000)
Stock issued for cash and conversion of notes payable, shares		2,336,255
Stock issued for cash and conversion of notes payable, amount	590,000	$ 3,000	587,000	0
Stock issued for services	0	$ 0	0	0
Stock compensation expense, shares		131,250
Stock compensation expense, amount	95,000	$ 0	95,000	0
Stock issued for asset acquisition of TrinIT, shares		730,000
Stock issued for asset acquisition of TrinIT , amount	183,000	$ 1,000	182,000	0
Net loss	(780,000)	$ 0	0	(780,000)
Balance, shares at Mar. 31, 2020		70,673,594
Balance, amount at Mar. 31, 2020	553,000	$ 71,000	75,602,000	(75,120,000)
Balance, shares at Dec. 31, 2019		67,476,089
Balance, amount at Dec. 31, 2019	465,000	$ 67,000	74,738,000	(74,340,000)
Net loss	(1,637,000)
Balance, shares at Jun. 30, 2020		73,473,452
Balance, amount at Jun. 30, 2020	205,000	$ 73,000	76,109,000	(75,977,000)
Balance, shares at Mar. 31, 2020		70,673,594
Balance, amount at Mar. 31, 2020	553,000	$ 71,000	75,602,000	(75,120,000)
Stock compensation expense, shares		1,617,861
Stock compensation expense, amount	225,000	$ 1,000	224,000	0
Net loss	(857,000)	$ 0	0	(857,000)
Stock issued for cash, shares		100,000
Stock issued for cash, amount	25,000	$ 0	25,000	0
Stock issued for conversion of note payable, shares		76,997
Stock issued for conversion of note payable, amount	8,000	$ 0	8,000	0
Stock issued for conversion of accounts payable, shares		1,000,000
Stock issued for conversion of accounts payable, amount	250,000	$ 1,000	249,000
Stock issued for stock option exercises, shares		5,000
Stock issued for stock option exercises, amount	1,000	$ 0	1,000	0
Balance, shares at Jun. 30, 2020		73,473,452
Balance, amount at Jun. 30, 2020	205,000	$ 73,000	76,109,000	(75,977,000)
Balance, shares at Dec. 31, 2020		90,081,336
Balance, amount at Dec. 31, 2020	(628,940)	$ 90,081	77,112,060	(77,831,081)
Stock compensation expense, shares		3,968,795
Stock compensation expense, amount	118,796	$ 3,969	114,827	0
Net loss	(812,914)	$ 0	0	(812,914)
Stock issued for cash, shares		22,504,600
Stock issued for cash, amount	1,417,313	$ 22,505	1,394,808	0
Stock issued for conversion of fees for services payable, shares		7,948,502
Stock issued for conversion of fees for services payable, amount	481,923	$ 7,948	473,975	0
Balance, shares at Mar. 31, 2021		124,503,233
Balance, amount at Mar. 31, 2021	576,178	$ 124,503	79,095,670	(78,643,995)
Balance, shares at Dec. 31, 2020		90,081,336
Balance, amount at Dec. 31, 2020	(628,940)	$ 90,081	77,112,060	(77,831,081)
Net loss	(2,396,147)
Balance, shares at Jun. 30, 2021		151,613,399
Balance, amount at Jun. 30, 2021	2,349,546	$ 151,613	82,425,161	(80,227,228)
Balance, shares at Mar. 31, 2021		124,503,233
Balance, amount at Mar. 31, 2021	576,178	$ 124,503	79,095,670	(78,643,995)
Stock compensation expense, shares		3,115,166
Stock compensation expense, amount	68,945	$ 3,115	65,830	0
Net loss	(1,583,233)	$ 0	0	(1,583,233)
Stock issued for cash, shares		16,015,000
Stock issued for cash, amount	1,503,500	$ 16,015	1,487,485	0
Stock issued for convertible debt, shares		2,730,000
Stock issued for convertible debt, amount	1,283,906	$ 2,730	1,281,176	0
Stock issued for asset acquisition of Advantech, shares		5,000,000
Stock issued for asset acquisition of Advantech, amount	500,000	$ 5,000	495,000
Stock issued for asset acquisition of BCS, shares		250,000
Stock issued for asset acquisition of BCS, amount	250	$ 250	0
Balance, shares at Jun. 30, 2021		151,613,399
Balance, amount at Jun. 30, 2021	$ 2,349,546	$ 151,613	$ 82,425,161	$ (80,227,228)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITTIES
Net loss	$ (2,396,147)	$ (1,637,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,418	5,000
Amortization expense	469,699	443,000
Loss on derivative liabilities	1,281,176	0
Change in allowance for doubtful accounts	0	0
Gain on cancellation of liabilities	(331,404)	0
Stock compensation expense	187,741	320,000
Non-cash interest expense	26,858	12,000
Changes in assets and liabilities:
Accounts receivable	(107,443)	(73,000)
Fixed assets	(4,228)	0
Prepaid expenses	(111,916)	2,000
Right of use asset, net of lease liability	(17,448)	(2,000)
Accounts payable and accrued expenses	(11,174)	255,000
Deferred revenue	(23,479)	(13,000)
NET CASH USED IN OPERATING ACTIVITIES	(1,036,347)	(688,000)
INVESTING ACTIVITIES
Cash portion of consideration paid to acquire Advantech/BCS	(1,850,022)	(375,000)
Additions to capitalized software	(108,752)	(311,000)
NET CASH USED IN INVESTING ACTIVITIES	(1,958,774)	(686,000)
FINANCING ACTIVITES
Net proceeds from debt	1,795,881	416,000
Payments on debt	(875,887)	(71,000)
Proceeds from issuance of common stock	2,920,813	595,000
Proceeds from exercise of employee stock options	0	1,000
Conversion of accounts payable into common stock	(7,266)
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,833,541	941,000
NET CHANGE IN CASH	838,420	(433,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD	7,619	445,000
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	846,039	12,000
Cash paid during the period for interest	233,465	49,000
Stock issued for acquisitions	500,250	183,000
Stock issued for acquisition of technology	0	0
Stock issued for conversion of convertible notes payable	0	28,000
Stock issued for conversion of notes payable	0	0
Stock issued for conversion of accounts payable	$ (7,266)	$ 250,000

NATURE OF OPERATIONS

NATURE OF OPERATIONS	6 Months Ended
	Jun. 30, 2021
NATURE OF OPERATIONS
1. NATURE OF OPERATIONS	1. NATURE OF OPERATIONS iCoreConnect Inc., (the “Company”), a Nevada Corporation, develops and markets secure cloud-based HIPAA compliant software as a service (SaaS) focused on compliance, workflow/productivity, and electronic health records systems. The Company also offers both managed IT (MSP) and managed software as a service (MSaaS) with recurring revenue subscriptions. Our core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial and education sectors. Software as a Service (SaaS) Offerings The Company currently markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The Company’s software is sold under annual recurring revenue subscriptions. iCoreExchange iCoreExchange provides a secure, HIPAA compliant email solution using the Direct Protocol that allows doctors to send and receive secure email with attachments to and from other healthcare professionals in the network. iCoreExchange also provides a secure email mechanism to communicate with users outside the exchange e.g., patients and referrals. Users have the ability to build a community, access other communities and increase referrals and collaboration. Users can email standard office documents, JPEG, PDF as well as files with discrete data, Consolidated Clinical Document Architecture (“CCDA”), which can then be imported and accessed on most Electronic Health Record (EHR) and Practice Management systems in a HIPAA compliant manner. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) requires providers and healthcare professionals to transmit encrypted personal health information via electronic means. iCoreCodeGenius Users can document any medical condition in 60 seconds or less. It includes a full ICD-10 code lookup and guidance, automatic prompting of comorbidities and Hierarchical Condition Category’s (HCC) appropriate reimbursement with a high degree of accuracy, and the ability to reduce or eliminate queries and denials. iCoreSecure iCoreMD iCoreDental -- Our cloud-based software was certified in November 2015 by the Office of the National Coordinator for Health Information Technology (ONC), certificate number 150120r0. iCoreMobile -- iCoreHuddle – iCoreRx – IT Managed Services - The MSP approach, by using preventative measures, keeps computers and networks up and running while data is accessible and safeguarded. Installation of critical patches and updates to virus protection are automated. Systems are monitored and backed up in real-time. They are fixed or upgraded before they cause a service disruption. A Unified Threat Management solution is deployed to protect against virus, malware, SPAM, phishing and ransomware attacks. All support is delivered at a predictable monthly cost. Going forward, by leveraging managed services with our expertise in cloud computing, our customers can easily scale their business without extensive capital investment or disruption in services. The Company is competitively positioned to address the growing need for managed services: · Our current and future customers need managed IT services, along with cloud computing, storage and HIPAA compliant backup and encryption. · Managed service providers that can support the migration to cloud computing are in high demand. · The decision makers for our current technology and those for managed services are, in many cases, the same person or group of people. · Our management team has decades of experience operating successful IT companies. · The MSP revenue model matches our SaaS, MSaaS and MRR models.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNFICANT ACCOUNTING POLICES Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to the Securities and Exchange Commission (“SEC”) rules and regulations. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2020, which are included in the Company’s Annual Report filed on Form 10-K with the SEC on April 15, 2021. The accompanying balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but does not include all information and footnotes required by GAAP for complete financial statements. The results of operations for the six-month period ended June 30, 2021 are not necessarily indicative of results that may be expected for any other interim period or for the full fiscal year. Readers of this Quarterly Report are strongly encouraged to review the risk factors relating to the Company which are set forth in the Company’s Form 10-K filed with the SEC. Basis of Presentation and Principles of Consolidations The accompanying consolidated financial statements are presented in United States dollars and include the accounts of the Company’s wholly owned subsidiaries, with all intercompany transactions eliminated. They have been prepared on the accrual basis in accordance with accounting principles generally accepted in the United States (GAAP). Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below. Fair Value of Financial Instruments The Company measures certain financial assets at fair value. Fair value is determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. Cash and Cash Equivalents The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at United States banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are customer obligations due under normal trade terms. We maintain an allowance for doubtful accounts for estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due us. Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability. If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required. In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts. The Company has estimated and recorded an allowance for doubtful accounts of $76,531 and $77,000 as of June 30, 2021 and December 31, 2020, respectively. Property, Equipment and Depreciation Property, equipment, and leasehold improvements are recorded at their historical cost. Depreciation and amortization have been determined using the straight-line method over the estimated useful lives of the assets which are computers and office equipment (3 years) and for office furniture and fixtures (7 years). The cost of repairs and maintenance is charged to operations in the period incurred. Software Development Costs and Acquired Software The Company accounts for software development costs, including costs to develop software products or the software component of products to be sold to external users. In accordance with ASC 985-730, Computer Software Research and Development, research and planning phase costs are expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs are capitalized. We have determined that technological feasibility for our products to be marketed to external users was reached before the release of those products. As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred. Capitalized costs for software to be sold to external users and software acquired in a business combination are amortized based on current and projected future revenue for each product with an annual minimum equal to the straight-line amortization over three years. Impairment of Long-Lived Assets Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount that the carrying amount of the asset exceeds the fair value of the asset. Goodwill Goodwill consists of the purchase price of business acquisitions in excess of the fair value of the net assets acquired. Goodwill is reviewed for impairment annually or when events or circumstances indicate that the carrying value of the reporting unit may exceed its fair value. If the carrying value of a reporting unit exceeds the fair value, an impairment loss will be recognized. The Company did not recognize any impairment charges for the fiscal quarter ended June 30, 2021 and 2020. We are required to test our goodwill for impairment at least annually, or more frequently if conditions indicate that an impairment may have occurred. Goodwill is tested for impairment at the asset level. Our reporting units are acquired companies at which discrete financial information may be available and for which operating results are regularly reviewed by our chief operating decision maker to allocate resources and assess performance. We have the option to qualitatively or quantitatively assess goodwill for impairment and, in 2020, we evaluated our goodwill using a qualitative assessment process. If the qualitative factors determine that it is more likely than not that the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired. If the qualitative assessment determines it is more likely than not the fair value is less than the carrying amount, we would further evaluate for potential impairment. As of June 30, 2021, we had $1.291 million of Goodwill on our balance sheet associated with four acquisitions, ICD Logic, TrinIT, and Advantech. ICD Logic related goodwill, which accounts for $0.361 million of the total Goodwill balance is the basis for the underlying technology associated with one of the Company’s faster growing and more promising SaaS offerings. TrinIT related Goodwill accounts for $0.130 million of the total Goodwill balance. The TrinIT acquisition was made in 2020 and is performing to expectations. Advantech accounted for $.799 million. During 2021, there were no indications of a triggering event at the 2 reporting units. The annual goodwill impairment analysis resulted in no indications of impairment in 2020 or 2019. We are subject to financial statement risk to the extent that our goodwill become impaired due to decreases in the fair value. A future decline in performance, decreases in projected growth rates or margin assumptions or changes in discount rates could result in a potential impairment, which could have a material adverse impact on our financial position and results of operations. Revenue Recognition We have 5 primary sources of revenue as of June 30, 2021: 1. ePrescription Software 2. IT Managed Services 3. Encrypted and HIPAA Compliant Secure email 4. ICD Coding Software 5. Electronic Health Records (EHR/Practice Management) software 1) ePrescription software services are provided on an annual basis using the software as a service (‘SaaS’) model with revenue recognized ratably over the contract term. 2) Managed IT services – Consist of 3 revenue streams. (i) Monthly recurring “Managed Service Provider (MSP)” and MSaaS revenue, (ii) periodic sale and installation of IT related hardware, and (iii) custom IT projects. The MSP and MSaaS model revenue is recognized monthly on a recurring basis while the revenue relating to IT hardware and custom IT projects is recognized when the services are performed. 3) Encrypted HIPAA compliant secure email services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 4) ICD Coding Software provides the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. ICD coding services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 5) Revenue from Practice Management software licensing arrangements are based on subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. We recognize revenue for our service in accordance with accounting standard ASC 606. Our customers are acquired through our own salesforce and through the referrals from our many state association marketing partners. We primarily generate revenue from multiple SaaS and MSaaS offerings, which typically include subscriptions to our online software solutions. The Company’s secondary source of revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Eighty-four percent of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America. Our customers do not have the right to take possession of the online software solution. Revenue from subscriptions, including additional fees for items such as incremental contacts, is recognized ratably over the subscription period beginning on the date the subscription is made available to customers. All subscription contracts are one year. We recognize revenue from on-boarding services and equipment as the services are provided. Amounts billed that have not yet met the applicable revenue recognition criteria are recorded as deferred revenue. Accounting for Derivative Instruments The Company accounts for derivative instruments in accordance with ASC 815, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability. Income Taxes The Company follows the asset and liability approach to accounting for income taxes. Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years. ASC 740, Accounting for Income taxes (“ASC 740”), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized. We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry forwarding periods available to us for tax reporting purposes and other relevant factors. The Company has not recognized a liability for uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty. If there were an unrecognized tax benefit or penalty, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company files U.S. Federal income tax returns and various returns in state jurisdictions. The Company’s open tax years subject to examination by the Internal Revenue Service and the state Departments of Revenue generally remain open for three years from the date of filing. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and to the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Net Loss Per Share Basic net loss per share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding for the period. Diluted net loss per share reflects the potential dilution of securities by adding other Common Stock equivalents, including stock options, shares issuable on exercise of warrants, convertible preferred stock and convertible notes in the weighted average number of common shares outstanding for a period, if dilutive. Common stock equivalents that are anti-dilutive were excluded from the computation of diluted earnings per share which consisted of all outstanding common stock options and warrants. Stock-Based Compensation The Company uses the fair value method to account for the granting of options to purchase shares of its stock whereby all awards are recorded at fair value on the date of the grant. Share based awards with a performance condition are measured based on the probable outcome of that performance condition during the requisite service period. Such an award with a performance condition is accrued if it is probable that a performance condition will be achieved. Compensation costs for stock-based payments that do not include performance conditions are recognized on a straight-line basis. The fair value of all share purchase options is expensed over their requisite service period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital. The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock on the option grant date. The Company estimates the volatility of its common stock at the date of grant based on its historical stock prices. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The fair value of shares of restricted stock issued are determined by the Company based on the estimated fair value of the Company’s common stock. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), The Company does not believe that any other issued, but not yet effective accounting standards, if currently adopted, will have a material effect on the Company’s consolidated financial position, results of operations and cash flows. Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. For the six-month period ended June 30, 2021, the Company generated an operating loss of $186,052. $80,227,228, $2,349,546 $2,072,335, Currently, management intends to develop a vastly improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

RESTATEMENT

RESTATEMENT	6 Months Ended
	Jun. 30, 2021
RESTATEMENT
3. RESTATEMENT	3. RESTATEMENT The following presents a reconciliation of the Balance Sheets, Statements of Operations and Statements of Cash Flows from the prior period previously reported to the restated amounts: iCoreConnect Inc. CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2021 (UNAUDITED) June 30, 2021 Restatement As Reported Adjustment As Restated ASSETS Cash and cash equivalents $ 846,039 $ 846,039 Accounts receivable, net 233,915 233,915 Prepaid expenses and other current assets 132,019 132,019 Total current assets 1,211,973 - 1,211,973 Property and equipment, net 15,090 15,090 Right of use lease asset - operating 118,182 118,182 Software development costs, net 698,349 698,349 Acquired technology, net 517,929 517,929 Customer relationships, net 1,855,664 1,855,664 Goodwill 1,291,109 1,291,109 Total long-term assets 4,496,323 - 4,496,323 TOTAL ASSETS $ 5,708,296 $ - $ 5,708,296 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Accounts payable and accrued expenses $ 833,416 $ 833,416 Operating lease liability, current portion 47,035 47,035 Notes payable 2,372,271 2,372,271 Deferred revenue, current portion 31,586 31,586 Total current liabilities 3,284,308 - 3,284,308 Operating lease liability, net of current portion 53,699 53,699 Deferred revenue, net of current portion 20,743 20,743 Total long-term liabilities 74,442 - 74,442 TOTAL LIABILITIES 3,358,750 - 3,358,750 STOCKHOLDERS' EQUITY (DEFICIT) Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 151,613,399 as of June 30, 2021 and 90,081,336 as of December 31, 2020 151,613 151,613 Additional paid-in-capital 81,143,985 1,281,176 82,425,161 Accumulated deficit (78,946,052 ) (1,281,176 ) (80,227,228 ) TOTAL STOCKHOLDERS' EQUITY (DEFICIT) 2,349,546 - 2,349,546 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 5,708,296 $ - $ 5,708,296 The accompanying notes are an integral part of these condensed consolidated financial statements iCoreConnect Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE SIX MONTH PERIOD ENDED JUNE 30, 2021 (UNAUDITED) Six Months Ended June 30, 2021 Restatement As Reported Adjustment As Restated Revenue $ 1,685,379 $ 1,685,379 Cost of sales 507,761 507,761 Gross profit 1,177,618 - 1,177,618 Expenses Selling, general and administrative 1,860,258 1,860,258 Depreciation and amortization 503,412 503,412 Total operating expenses 2,363,670 - 2,363,670 Loss from operations (1,186,052 ) - (1,186,052 ) Other income (expense) Interest expense (260,323 ) (260,323 ) Loss on derivative liability - (1,281,176 ) (1,281,176 ) Gain on cancellation of liabilities 331,404 331,404 Total other income (expense) 71,081 (1,281,176 ) (1,210,095 ) Net loss $ (1,114,971 ) $ (1,281,176 ) $ (2,396,147 ) The accompanying notes are an integral part of these condensed consolidated financial statements iCoreConnect Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2021 (UNAUDITED) Six Months Ended June 30, 2021 Restatement As Reported Adjustment As Restated CASH FLOWS FROM OPERATING ACTIVITTIES Net loss $ (1,114,971 ) $ (1,281,176 ) $ (2,396,147 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense 1,418 1,418 Amortization expense 469,699 469,699 Loss on derivative liability - - Change in allowance for doubtful accounts (331,404 ) (331,404 ) Gain on cancellation of liabilities - 1,281,176 1,281,176 Stock compensation expense 187,741 187,741 Non-cash interest expense 26,858 26,858 Changes in assets and liabilities: - - Accounts receivable (107,443 ) (107,443 ) Fixed assets (4,228 ) (4,228 ) Prepaid expenses (111,916 ) (111,916 ) Right of use asset, net of lease liability (17,448 ) (17,448 ) Accounts payable and accrued expenses (11,174 ) (11,174 ) Deferred revenue (23,479 ) (23,479 ) NET CASH USED IN OPERATING ACTIVITIES $ (1,036,347 ) $ - $ (1,036,347 ) INVESTING ACTIVITIES Cash portion of consideration paid to acquire Advantech/BCS $ (1,850,022 ) $ (1,850,022 ) Additions to capitalized software (108,752 ) (108,752 ) NET CASH USED IN INVESTING ACTIVITIES $ (1,958,774 ) $ - $ (1,958,774 ) FINANCING ACTIVITES Net proceeds from debt $ 1,795,881 $ 1,795,881 Payments on debt (875,887 ) (875,887 ) Proceeds from issuance of common stock 2,920,813 2,920,813 Proceeds from exercise of employee stock options - - Conversion of accounts payable into common stock (7,266 ) (7,266 ) NET CASH PROVIDED BY FINANCING ACTIVITIES $ 3,833,541 $ - $ 3,833,541 NET CHANGE IN CASH $ 838,420 $ - $ 838,420 CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD 7,619 7,619 CASH AND CASH EQUIVALENTS AT END OF THE PERIOD $ 846,039 $ - $ 846,039 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid during the period for interest $ 233,465 $ - $ 233,465 Stock issued for acquisitions $ 500,250 $ - $ 500,250 Stock issued for acquisition of technology $ - $ - $ - Stock issued for conversion of convertible notes payable $ - $ - $ - Stock issued for conversion of notes payable $ (7,266 ) $ - $ (7,266 ) Stock issued for conversion of accounts payable

NOTES PAYABLE AND DERIVATIVE LI

NOTES PAYABLE AND DERIVATIVE LIABILITY	6 Months Ended
	Jun. 30, 2021
NOTES PAYABLE AND DERIVATIVE LIABILITY
4. NOTES PAYABLE AND DERIVATIVE LIABILITY	4. NOTES PAYABLE AND DERIVATIVE LIABILITY Notes Payable The Company issued a note payable to a related party on December 31, 2018 with a principal amount of $714,000, bearing interest at a rate of 18% per annum, with monthly principal and accrued interest payments and with a balloon payment due by the maturity date of December 31, 2019. The balloon payment due on December 31, 2019 was not made and the Company issued, in exchange for the original note, a new note dated December 31, 2019 with a principal amount of $556,000, bearing interest at a rate of 18% per annum, with monthly principal and accrued interest payments and a balloon payment due by the maturity date of December 31, 2020.The amounts owing on the note as of December 31, 2019 were $556,000 of principal plus a nominal amount of accrued interest.As of December 31, 2020, $535,021 of principal was outstanding on this note payable. Subsequent to the end of fiscal 2020, the maturity on note payable to the related party was extended to a new 2-year term note payable bearing interest rate payable of 18% per annum with a maturity date of December 31, 2023. The note will pay monthly cash interest only in the first year (12 months) of note payable term. In the 2nd year, the note payable will be repaid with 12 monthly installment payments of interest and principal until fully repaid. In April 2021, the Company signed a $150,000 convertible promissory note with a maturity date twelve months after issuance and received in exchange $150,000 from a finance company (the “Investor” or “Holder”). An Interest charge of 12% per annum shall accrue and be paid on the maturity date. The note is convertible into the Company’s Common Stock at fixed conversion price $0.10 per common share. The Company has right of prepayment. The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. The Company also issued to the Holder 780,000 restricted shares of the Company’s Common Stock and 2,600,000 cash Warrant Shares with a 5-year term. The exercise price per share of Common Stock under this Warrant is $0.20 per share for the first 1,300,000 Warrant Shares and $0.25 for the next 1,300,000 Warrant Shares. In April 2021, the Company signed a $350,000 convertible promissory note with a maturity date twelve months after issuance and received in exchange $350,000 from the same finance company (the “Investor” or “Holder”). An Interest charge of 12% per annum shall accrue and be paid on the maturity date. The note is convertible into the Company’s Common Stock at a fixed conversion price of $0.10 per common share. The Company has right of prepayment. The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. In April 2021, the Company signed a $500,000 convertible promissory note with a maturity date twelve months after issuance and received in exchange $500,000 from a second finance company (the “Investor” or “Holder”). An Interest charge of 12% per annum shall accrue and be paid on the maturity date. The note is convertible into the Company’s Common Stock at a fixed conversion price of $0.10 per common share. The Company has right of prepayment. The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. The company also issued to the Holder 788,000 restricted shares of the Company’s Common Stock and 2,600,000 cash Warrant Shares with a 5-year term. The exercise price per share of Common stock under this Warrant is $0.20 per share for the first 1,300,000 Warrant Shares and $0.25 for the next 1,300,000 Warrant Shares. In April 2021, the Company signed a $250,000 convertible promissory note with a maturity date twelve months after issuance and received in exchange $250,000 from a third finance company (the “Investor” or “Holder”). An Interest charge of 12% per annum shall accrue and be paid on the maturity date. The note is convertible into the Company’s Common Stock at fixed conversion price $0.10 per common share. The Company has right of prepayment. The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. The Company also issued to the Holder 390,000 restricted shares of the Company’s Common Stock and 1,300,000 cash Warrant Shares with a 5-year term. The exercise price per share of Common stock under this Warrant is $0.20 per share for the first 650,000 Warrant Shares and $0.25 for the next 650,000 Warrant Shares. In April 2021, the Company signed a $250,000 convertible promissory note with a maturity date twelve months after issuance and received in exchange $230,000 net of fees from a fourth finance company (the “Investor” or “Holder”). An Interest charge of 12% per annum shall accrue and be paid on the maturity date. The note is convertible into the Company’s Common Stock at fixed conversion price $0.10 per common share. The Company has right of prepayment. The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. The Company also issued to the Holder 390,000 restricted shares of the Company’s Common Stock and 1,300,000 cash Warrant Shares with a 5-year term. The exercise price per share of Common stock under this Warrant is $0.20 per share for the first 650,000 Warrant Shares and $0.25 for the next 650,000 Warrant Shares. Derivative Liability The Company entered into several agreements, which have been accounted for as derivatives. The Company has recorded a loss contingency associated with these agreements because it is both probable that a liability had been incurred and the amount of the loss can reasonably be estimated. The main factors that will affect the fair value of the derivative are the number of the Company’s shares outstanding post acquisition or post offering and the resulting market capitalization. ASC Topic 815 (“ASC 815” requires that all derivative financial instruments be recorded on the balance sheet at fair value. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgement and estimates. The Company issued warrants and has evaluated the terms and conditions of the conversion features contained in the warrants to determine whether they represent embedded or freestanding derivative instruments under the provisions of ASC 815. The Company determined that the conversion features contained in the warrants represent freestanding derivative instruments that meet the requirements for liability classification under ASC 815. As a result, the fair value of the derivative financial instruments in the warrants is reflected in the Company’s balance sheet as a liability. The fair value of the derivative financial instruments of the warrants was measured at the inception date of the warrants and each subsequent balance sheet date. Any changes in the fair value of the derivative financial instruments are recorded as non-operating, non-cash income, or expense at each balance sheet date. Additionally, the Company has issued convertible notes with variable conversion features resulting in a derivative liability. The Company valued the conversion features in its warrants and convertible notes using the Black-Scholes model. Included in the June 30, 2021 and December 31, 2020 financial statements is a derivative liability in the amount of $592,023 and $0, respectively, to account for these transaction. It is revalued quarterly henceforth and adjusted as a gain or loss to the consolidated statements of operations depending on its value at that time. June 30, December 31, 2021 2020 Derivative Liability - Warrants Estimated number of underlying shares 9,100,000 - Estimated market price per share $ - $ - Exercise price per share $ 0.20 to $0.25 $ - Expected volatility 291 % 0 % Expected dividends - - Expected term (in years) 10 - Derivative liability $ 592,023 $ - Derivative Liability - Convertible Notes Estimated number of underlying shares 2,730,000 - Estimated market price per share $ 0.13 $ - Exercise price per share $ 0.10 $ - Expected volatility 291 % 0 % Expected dividends - - Expected term (in years) 2 - Derivative liability $ 349,488 $ - Included in the Statements of Operations for the six months ended June 30, 2021 and June 30, 2020 is a loss of $(1,281,177) and $0 in change of fair value of derivative in non-cash charges pertaining to the derivative liability as it pertains to the gain (loss) on derivative liability and debt discount, respectively.

COMMON STOCK

COMMON STOCK	6 Months Ended
	Jun. 30, 2021
COMMON STOCK
5. COMMON STOCK	5. Stock Issuances In January of 2021, executives and employees converted notes payable and services rendered of $481,923 into approximately 7.9 million shares of Common Stock. In the first and second quarter of 2021, the Company issued approximately 38.5 million shares of Common stock for $2.920 million in cash. In January of 2021, the Company and a finance company entered into a Purchase Agreement between the Company and an Investor (the “Investor”). The Purchase Agreement is an equity line of credit and the Investor committed to purchase, subject to certain restrictions and conditions, up to $5.0 million worth (the “Commitment”) of the Company’s common stock over a period of 24 months from the effectiveness of the registration statement registering for resale shares purchased by the Investor pursuant to the Purchase Agreement. The Company has no other lines of credit as of June 30, 2021. Stock Options During the six-month period ended June 30, 2021, no options to purchase shares of common stock granted to employees expired and no options were forfeited or exercised. A summary of option activity for the six-month period ended June 30, 2021, is presented below: 2021 Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance Outstanding - January 1, 2021 1,405,000 $ 0.24 7.7 $ - Granted - $ - Exercised - $ - Forfeited - $ - Balance Outstanding - June 30, 2021 1,405,000 $ 0.24 7.4 $ - Exercisable - June 31, 2021 1,405,000 $ 0.24 7.4 $ - 2021 Nonvested Options Number of Options Weighted Average Grant Date Fair Value Weighted Average Remaining Years to Vest Nonvested - January 1, 2021 - $ - 0.0 Granted - $ - Vested - $ - Forfeited/expired - Nonvested - June 30, 2021 - $ - 0.00 Common Stock Warrants The Company typically issues warrants to individual investors and institutions to purchase shares of the Company’s Common Stock in connection with public and private placement fundraising activities. Warrants may also be issued to individuals or companies in exchange for services provided for the Company. The warrants are typically exercisable six months after the issue date, expire in five years, and contain a cash exercise provision and registration rights. Common Stock Warrants - In April and May of 2021, in connection with the issuance of the Company’s Convertible Promissory Notes, the Company issued warrants to purchase the Company’s Common Stock. These warrants were designated Common Stock Warrants with an initial term of 5 years and an exercise prices of $0.20 and $0.25. The Company may not effect, and a holder will not be entitled to, convert the Common Stock Warrants, which, upon giving effect to such conversion or exercise, would cause the aggregate number of shares of common stock beneficially owned by the Purchaser (together with its affiliates) to exceed 4.99%. As of June 30, 2021, the number of shares issuable upon exercise of the Common Stock Warrants were 9.1 million shares. Type Issue Date Shares Price Expiration Investors 4/19/2021 1,300,000 $ 0.20 4/19/2026 Investors 4/19/2021 1,300,000 $ 0.25 4/19/2026 Investors 4/22/2021 1,300,000 $ 0.20 4/22/2026 Investors 4/22/2021 1,300,000 $ 0.25 4/22/2026 Investors 4/30/2021 650,000 $ 0.20 4/30/2026 Investors 4/30/2021 650,000 $ 0.25 4/30/2026 Investors 5/4/2021 650,000 $ 0.20 5/4/2026 Investors 5/4/2021 650,000 $ 0.25 5/4/2026 Investors 5/19/2021 650,000 $ 0.20 5/19/2026 Investors 5/19/2021 650,000 $ 0.25 5/16/2026 Total 9,100,000

SOFTWARE DEVELOPMENT COSTS

SOFTWARE DEVELOPMENT COSTS	6 Months Ended
	Jun. 30, 2021
SOFTWARE DEVELOPMENT COSTS
6. SOFTWARE DEVELOPMENT COSTS	6. The Company continued to develop its software products with significant features and enhancements during the six-month period ended June 30, 2021 and has continued to capitalize development costs during that period. A summary of the capitalization and amortization of the software development costs is as follows: June 30, December 31, 2021 2020 Development costs $ 2,587,889 $ 2,479,137 Acquired technology 1,527,186 1,527,186 Less accumulated amortization (2,898,798 ) (2,483,622 ) $ 1,216,278 $ 1,522,701

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2021
COMMITMENTS AND CONTINGENCIES
7. COMMITMENTS AND CONTINGENCIES	7. COMMITMENTS AND CONTINGENCIES On November 15, 2017, the Company signed a three-year lease agreement for approximately 4,100 square feet of office space located in Winter Garden, Florida in which the Company has its headquarters. The lease provided for a one-year renewal term at the option of the Company that the company exercised. An amendment to this lease was signed on October 26, 2020 which extended the lease term through October 31, 2021. The company signed a three-year lease agreement for approximately 2.100 square feet of office space located in Concord, NC on July 16, 2020. With the acquisition of Advantech, the Company signed a two-year lease on May 12, 2021 for an office in Scottsdale, AZ. As of June 30, 2021, undiscounted future lease obligations for the office space are $131,660 for period ending June 30, 2021. On January 1, 2019, the Company adopted ASU 2016-02, Leases (Topic 842), iCoreConnect Lease Commitments as of 6/30/2021 Less than 1 year 1-3 years 3-5 years Total $ 73,980 $ 57,680 $ 0 $ 131,660 Lease costs for the 6 months ending June 30, 2021 were $72,880 and cash paid for amounts included in the measurement of lease liabilities for the quarter ended June 30, 2020 were 44,000. As of December 31, 2020, the following represents the difference between the remaining undiscounted lease commitments under non-cancelable leases and the lease liabilities: Undiscounted minimum lease commitments $ 131,660 Present value adjustment using incremental borrowing rate (30,926 ) Lease liabilities $ 100,734

CONCENTRATION OF CREDIT RISK

CONCENTRATION OF CREDIT RISK	6 Months Ended
	Jun. 30, 2021
CONCENTRATION OF CREDIT RISK
8. CONCENTRATION OF CREDIT RISK	8. The Company has historically provided financial terms to customers in accordance with what management views as industry norms. Access to the Company’s software products usually requires immediate payment but can extend several months under certain circumstances. Management periodically and regularly reviews customer account activity in order to assess the adequacy of allowances for doubtful accounts, considering such factors as economic conditions and each customer’s payment history and creditworthiness. If the financial condition of our customers were to deteriorate, or if they were otherwise unable to make payments in accordance with management’s expectations, we might have to increase our allowance for doubtful accounts, modify their financial terms and/or pursue alternative collection methods. The company had no significant customer (greater than 10% of total revenue) for 6 months ending June 30, 2021. The Company had 1 significant customer in the six months ending June 30, 2020. The customer’s share of total revenue fell to under 10% from the 6 months ending June 30, 2020 due to organic growth of other customers and the acquisition of TrinIT and Advantech that further diversified the Company’s customer concentration. The company has accounts receivable concentration with three customers that represent 20%, 11%, and 11% of our accounts receivable. Overall, the company grew its accounts receivable approximately ending balance 29% for the 6 months ending June 30, 2021 compared to the 6 months ending June 30, 2020, compared to an over 71% growth in sales for the same period. Day’s sales outstanding was less than 30 days as of June 30, 2021.

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
	Jun. 30, 2021
SEGMENT INFORMATION
9. SEGMENT INFORMATION	9. The Company views its operations and manages its business as one operating segment which is the business of providing subscription based software as a service (SaaS) and Managed IT (MSP/MSaaS) services and related non-recurring professional IT and other services. The Company aggregates is operating segments based on similar economic and operating characteristics of its operations. The Company’s SaaS and Managed IT offerings are sold under monthly recurring revenue contracts are included in the Subscription software and services segment. Professional services and other revenue segment consists of non-recurring revenue, including the periodic sale and installation of IT related hardware and custom IT projects. Professional services and other revenue is recognized when services are performed. Revenue Segment Net sales by revenue type were as follows: For the Six Months Ended June 30, 2021 % 2020 % % Change Revenues: Subscription software and services $ 1,464,629 87 % $ 778,245 80 % 88 % Professional services and other 220,750 13 % 199,619 20 % 11 % Total $ 1,685,379 100 % $ 977,863 100 % 72 %

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2021
RELATED PARTY TRANSACTIONS
10. RELATED PARTY TRANSACTIONS	10. RELATED PARTY TRANSACTIONS The Company paid one of its officers $45,872 and $48,338.73 in interest payments for the periods June 30, 2021 and June 30, 2020 respectively, related to a Note Payable.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2021
SUBSEQUENT EVENTS
11. SUBSEQUENT EVENTS	11. The Company completed its acquisition of with Spectrum Technology Solutions, LLC on September 1, 2021. In conjunction with the acquisition the Company issued $1,500,000 of Notes Payable to an existing debt issuer including warrants and inducement shares of 1,500,000 and 1,000,000 respectively as well as issuing $500,000worth of the Company’s stock. On August 18, 2021 the Company received a Notice of Disposition of Collateral under section 9-611 of the Uniform Commercial Code (“UCC”) (Arizona Revised Statutes 47-611) purporting to set a foreclosure sale, under the UCC, of the Company’s assets that were previously pledged as security to a Lender. On August 24, 2021 the Company received a Default Notice from the Lender asserting that the Company was obligated to pay $863,274. The Lender alleged that it had made certain loans and other financial accommodations in the form of guaranties to our Company beginning in approximately of March of 2009 that was secured by all of the assets our Company. We initiated an investigation into the matter and concluded that we had repaid all of the loans (including tendering payment of $28,577.82 for various credit card obligations with JP Morgan Chase Bank which the Lender rejected on August 4, 2021) and any loans that had not been repaid were released under the terms of a Recapitalization Agreement dated November 1, 2016. We then retained Arizona counsel to prepare an Emergency Application for Temporary Restraining Order and Preliminary Injunction against the Lender in order to stop the foreclosure sale. We are currently in negotiations with Lender to resolve the dispute. We believe the claims of the Lender are without merit and intend to vigorously defend the matter.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidations	The accompanying consolidated financial statements are presented in United States dollars and include the accounts of the Company’s wholly owned subsidiaries, with all intercompany transactions eliminated. They have been prepared on the accrual basis in accordance with accounting principles generally accepted in the United States (GAAP). Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below.
Fair Value of Financial Instruments	The Company measures certain financial assets at fair value. Fair value is determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
Cash and Cash Equivalents	The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at United States banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts receivable are customer obligations due under normal trade terms. We maintain an allowance for doubtful accounts for estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due us. Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability. If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required. In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts. The Company has estimated and recorded an allowance for doubtful accounts of $76,531 and $77,000 as of June 30, 2021 and December 31, 2020, respectively.
Property, Equipment and Depreciation	Property, equipment, and leasehold improvements are recorded at their historical cost. Depreciation and amortization have been determined using the straight-line method over the estimated useful lives of the assets which are computers and office equipment (3 years) and for office furniture and fixtures (7 years). The cost of repairs and maintenance is charged to operations in the period incurred.
Software Development Costs and Acquired Software	The Company accounts for software development costs, including costs to develop software products or the software component of products to be sold to external users. In accordance with ASC 985-730, Computer Software Research and Development, research and planning phase costs are expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs are capitalized. We have determined that technological feasibility for our products to be marketed to external users was reached before the release of those products. As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred. Capitalized costs for software to be sold to external users and software acquired in a business combination are amortized based on current and projected future revenue for each product with an annual minimum equal to the straight-line amortization over three years.
Impairment of Long-Lived Assets	Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount that the carrying amount of the asset exceeds the fair value of the asset.
Goodwill	Goodwill consists of the purchase price of business acquisitions in excess of the fair value of the net assets acquired. Goodwill is reviewed for impairment annually or when events or circumstances indicate that the carrying value of the reporting unit may exceed its fair value. If the carrying value of a reporting unit exceeds the fair value, an impairment loss will be recognized. The Company did not recognize any impairment charges for the fiscal quarter ended June 30, 2021 and 2020. We are required to test our goodwill for impairment at least annually, or more frequently if conditions indicate that an impairment may have occurred. Goodwill is tested for impairment at the asset level. Our reporting units are acquired companies at which discrete financial information may be available and for which operating results are regularly reviewed by our chief operating decision maker to allocate resources and assess performance. We have the option to qualitatively or quantitatively assess goodwill for impairment and, in 2020, we evaluated our goodwill using a qualitative assessment process. If the qualitative factors determine that it is more likely than not that the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired. If the qualitative assessment determines it is more likely than not the fair value is less than the carrying amount, we would further evaluate for potential impairment. As of June 30, 2021, we had $1.291 million of Goodwill on our balance sheet associated with four acquisitions, ICD Logic, TrinIT, and Advantech. ICD Logic related goodwill, which accounts for $0.361 million of the total Goodwill balance is the basis for the underlying technology associated with one of the Company’s faster growing and more promising SaaS offerings. TrinIT related Goodwill accounts for $0.130 million of the total Goodwill balance. The TrinIT acquisition was made in 2020 and is performing to expectations. Advantech accounted for $.799 million. During 2021, there were no indications of a triggering event at the 2 reporting units. The annual goodwill impairment analysis resulted in no indications of impairment in 2020 or 2019. We are subject to financial statement risk to the extent that our goodwill become impaired due to decreases in the fair value. A future decline in performance, decreases in projected growth rates or margin assumptions or changes in discount rates could result in a potential impairment, which could have a material adverse impact on our financial position and results of operations.
Revenue Recognition	We have 5 primary sources of revenue as of June 30, 2021: 1. ePrescription Software 2. IT Managed Services 3. Encrypted and HIPAA Compliant Secure email 4. ICD Coding Software 5. Electronic Health Records (EHR/Practice Management) software 1) ePrescription software services are provided on an annual basis using the software as a service (‘SaaS’) model with revenue recognized ratably over the contract term. 2) Managed IT services – Consist of 3 revenue streams. (i) Monthly recurring “Managed Service Provider (MSP)” and MSaaS revenue, (ii) periodic sale and installation of IT related hardware, and (iii) custom IT projects. The MSP and MSaaS model revenue is recognized monthly on a recurring basis while the revenue relating to IT hardware and custom IT projects is recognized when the services are performed. 3) Encrypted HIPAA compliant secure email services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 4) ICD Coding Software provides the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. ICD coding services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 5) Revenue from Practice Management software licensing arrangements are based on subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. We recognize revenue for our service in accordance with accounting standard ASC 606. Our customers are acquired through our own salesforce and through the referrals from our many state association marketing partners. We primarily generate revenue from multiple SaaS and MSaaS offerings, which typically include subscriptions to our online software solutions. The Company’s secondary source of revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Eighty-four percent of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America. Our customers do not have the right to take possession of the online software solution. Revenue from subscriptions, including additional fees for items such as incremental contacts, is recognized ratably over the subscription period beginning on the date the subscription is made available to customers. All subscription contracts are one year. We recognize revenue from on-boarding services and equipment as the services are provided. Amounts billed that have not yet met the applicable revenue recognition criteria are recorded as deferred revenue.
Accounting for Derivative Instruments	The Company accounts for derivative instruments in accordance with ASC 815, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.
Income Taxes	The Company follows the asset and liability approach to accounting for income taxes. Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years. ASC 740, Accounting for Income taxes (“ASC 740”), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized. We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry forwarding periods available to us for tax reporting purposes and other relevant factors. The Company has not recognized a liability for uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty. If there were an unrecognized tax benefit or penalty, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company files U.S. Federal income tax returns and various returns in state jurisdictions. The Company’s open tax years subject to examination by the Internal Revenue Service and the state Departments of Revenue generally remain open for three years from the date of filing.
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and to the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.
Net Loss Per Share	Basic net loss per share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding for the period. Diluted net loss per share reflects the potential dilution of securities by adding other Common Stock equivalents, including stock options, shares issuable on exercise of warrants, convertible preferred stock and convertible notes in the weighted average number of common shares outstanding for a period, if dilutive. Common stock equivalents that are anti-dilutive were excluded from the computation of diluted earnings per share which consisted of all outstanding common stock options and warrants.
Stock-Based Compensation	The Company uses the fair value method to account for the granting of options to purchase shares of its stock whereby all awards are recorded at fair value on the date of the grant. Share based awards with a performance condition are measured based on the probable outcome of that performance condition during the requisite service period. Such an award with a performance condition is accrued if it is probable that a performance condition will be achieved. Compensation costs for stock-based payments that do not include performance conditions are recognized on a straight-line basis. The fair value of all share purchase options is expensed over their requisite service period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital. The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock on the option grant date. The Company estimates the volatility of its common stock at the date of grant based on its historical stock prices. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The fair value of shares of restricted stock issued are determined by the Company based on the estimated fair value of the Company’s common stock.
Recently Issued Accounting Pronouncements	In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), The Company does not believe that any other issued, but not yet effective accounting standards, if currently adopted, will have a material effect on the Company’s consolidated financial position, results of operations and cash flows.
Going Concern	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. For the six-month period ended June 30, 2021, the Company generated an operating loss of $186,052. $80,227,228, $2,349,546 $2,072,335, Currently, management intends to develop a vastly improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

RESTATEMENT (Tables)

RESTATEMENT (Tables)	6 Months Ended
	Jun. 30, 2021
RESTATEMENT
Summary of reconciliation of the Balance Sheets	iCoreConnect Inc. CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2021 (UNAUDITED) June 30, 2021 Restatement As Reported Adjustment As Restated ASSETS Cash and cash equivalents $ 846,039 $ 846,039 Accounts receivable, net 233,915 233,915 Prepaid expenses and other current assets 132,019 132,019 Total current assets 1,211,973 - 1,211,973 Property and equipment, net 15,090 15,090 Right of use lease asset - operating 118,182 118,182 Software development costs, net 698,349 698,349 Acquired technology, net 517,929 517,929 Customer relationships, net 1,855,664 1,855,664 Goodwill 1,291,109 1,291,109 Total long-term assets 4,496,323 - 4,496,323 TOTAL ASSETS $ 5,708,296 $ - $ 5,708,296 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Accounts payable and accrued expenses $ 833,416 $ 833,416 Operating lease liability, current portion 47,035 47,035 Notes payable 2,372,271 2,372,271 Deferred revenue, current portion 31,586 31,586 Total current liabilities 3,284,308 - 3,284,308 Operating lease liability, net of current portion 53,699 53,699 Deferred revenue, net of current portion 20,743 20,743 Total long-term liabilities 74,442 - 74,442 TOTAL LIABILITIES 3,358,750 - 3,358,750 STOCKHOLDERS' EQUITY (DEFICIT) Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 151,613,399 as of June 30, 2021 and 90,081,336 as of December 31, 2020 151,613 151,613 Additional paid-in-capital 81,143,985 1,281,176 82,425,161 Accumulated deficit (78,946,052 ) (1,281,176 ) (80,227,228 ) TOTAL STOCKHOLDERS' EQUITY (DEFICIT) 2,349,546 - 2,349,546 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 5,708,296 $ - $ 5,708,296 The accompanying notes are an integral part of these condensed consolidated financial statements
Summary of Summary of reconciliation of the Statements of Operations	iCoreConnect Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE SIX MONTH PERIOD ENDED JUNE 30, 2021 (UNAUDITED) Six Months Ended June 30, 2021 Restatement As Reported Adjustment As Restated Revenue $ 1,685,379 $ 1,685,379 Cost of sales 507,761 507,761 Gross profit 1,177,618 - 1,177,618 Expenses Selling, general and administrative 1,860,258 1,860,258 Depreciation and amortization 503,412 503,412 Total operating expenses 2,363,670 - 2,363,670 Loss from operations (1,186,052 ) - (1,186,052 ) Other income (expense) Interest expense (260,323 ) (260,323 ) Loss on derivative liability - (1,281,176 ) (1,281,176 ) Gain on cancellation of liabilities 331,404 331,404 Total other income (expense) 71,081 (1,281,176 ) (1,210,095 ) Net loss $ (1,114,971 ) $ (1,281,176 ) $ (2,396,147 ) The accompanying notes are an integral part of these condensed consolidated financial statements
Summary of Summary of Summary of reconciliation of the Statements of Cash Flow	iCoreConnect Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2021 (UNAUDITED) Six Months Ended June 30, 2021 Restatement As Reported Adjustment As Restated CASH FLOWS FROM OPERATING ACTIVITTIES Net loss $ (1,114,971 ) $ (1,281,176 ) $ (2,396,147 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense 1,418 1,418 Amortization expense 469,699 469,699 Loss on derivative liability - - Change in allowance for doubtful accounts (331,404 ) (331,404 ) Gain on cancellation of liabilities - 1,281,176 1,281,176 Stock compensation expense 187,741 187,741 Non-cash interest expense 26,858 26,858 Changes in assets and liabilities: - - Accounts receivable (107,443 ) (107,443 ) Fixed assets (4,228 ) (4,228 ) Prepaid expenses (111,916 ) (111,916 ) Right of use asset, net of lease liability (17,448 ) (17,448 ) Accounts payable and accrued expenses (11,174 ) (11,174 ) Deferred revenue (23,479 ) (23,479 ) NET CASH USED IN OPERATING ACTIVITIES $ (1,036,347 ) $ - $ (1,036,347 ) INVESTING ACTIVITIES Cash portion of consideration paid to acquire Advantech/BCS $ (1,850,022 ) $ (1,850,022 ) Additions to capitalized software (108,752 ) (108,752 ) NET CASH USED IN INVESTING ACTIVITIES $ (1,958,774 ) $ - $ (1,958,774 ) FINANCING ACTIVITES Net proceeds from debt $ 1,795,881 $ 1,795,881 Payments on debt (875,887 ) (875,887 ) Proceeds from issuance of common stock 2,920,813 2,920,813 Proceeds from exercise of employee stock options - - Conversion of accounts payable into common stock (7,266 ) (7,266 ) NET CASH PROVIDED BY FINANCING ACTIVITIES $ 3,833,541 $ - $ 3,833,541 NET CHANGE IN CASH $ 838,420 $ - $ 838,420 CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD 7,619 7,619 CASH AND CASH EQUIVALENTS AT END OF THE PERIOD $ 846,039 $ - $ 846,039 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid during the period for interest $ 233,465 $ - $ 233,465 Stock issued for acquisitions $ 500,250 $ - $ 500,250 Stock issued for acquisition of technology $ - $ - $ - Stock issued for conversion of convertible notes payable $ - $ - $ - Stock issued for conversion of notes payable $ (7,266 ) $ - $ (7,266 ) Stock issued for conversion of accounts payable

NOTES PAYABLE AND DERIVATIVE _2

NOTES PAYABLE AND DERIVATIVE LIABILITY (Tables)	6 Months Ended
	Jun. 30, 2021
NOTES PAYABLE AND DERIVATIVE LIABILITY
Summary of conversion features in its warrants and convertible notes using the Black-Scholes model	June 30, December 31, 2021 2020 Derivative Liability - Warrants Estimated number of underlying shares 9,100,000 - Estimated market price per share $ - $ - Exercise price per share $ 0.20 to $0.25 $ - Expected volatility 291 % 0 % Expected dividends - - Expected term (in years) 10 - Derivative liability $ 592,023 $ - Derivative Liability - Convertible Notes Estimated number of underlying shares 2,730,000 - Estimated market price per share $ 0.13 $ - Exercise price per share $ 0.10 $ - Expected volatility 291 % 0 % Expected dividends - - Expected term (in years) 2 - Derivative liability $ 349,488 $ -

COMMON STOCK (Tables)

COMMON STOCK (Tables)	6 Months Ended
	Jun. 30, 2021
COMMON STOCK (Tables)
Summary of stock option activity	2021 Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance Outstanding - January 1, 2021 1,405,000 $ 0.24 7.7 $ - Granted - $ - Exercised - $ - Forfeited - $ - Balance Outstanding - June 30, 2021 1,405,000 $ 0.24 7.4 $ - Exercisable - June 31, 2021 1,405,000 $ 0.24 7.4 $ - 2021 Nonvested Options Number of Options Weighted Average Grant Date Fair Value Weighted Average Remaining Years to Vest Nonvested - January 1, 2021 - $ - 0.0 Granted - $ - Vested - $ - Forfeited/expired - Nonvested - June 30, 2021 - $ - 0.00
Schedule of share issuable warrants	Type Issue Date Shares Price Expiration Investors 4/19/2021 1,300,000 $ 0.20 4/19/2026 Investors 4/19/2021 1,300,000 $ 0.25 4/19/2026 Investors 4/22/2021 1,300,000 $ 0.20 4/22/2026 Investors 4/22/2021 1,300,000 $ 0.25 4/22/2026 Investors 4/30/2021 650,000 $ 0.20 4/30/2026 Investors 4/30/2021 650,000 $ 0.25 4/30/2026 Investors 5/4/2021 650,000 $ 0.20 5/4/2026 Investors 5/4/2021 650,000 $ 0.25 5/4/2026 Investors 5/19/2021 650,000 $ 0.20 5/19/2026 Investors 5/19/2021 650,000 $ 0.25 5/16/2026 Total 9,100,000

SOFTWARE DEVELOPMENT COSTS (Tab

SOFTWARE DEVELOPMENT COSTS (Tables)	6 Months Ended
	Jun. 30, 2021
SOFTWARE DEVELOPMENT COSTS (Tables)
Summary of capitalization and amortization of software development costs	June 30, December 31, 2021 2020 Development costs $ 2,587,889 $ 2,479,137 Acquired technology 1,527,186 1,527,186 Less accumulated amortization (2,898,798 ) (2,483,622 ) $ 1,216,278 $ 1,522,701

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2021
COMMITMENTS AND CONTINGENCIES
Summary of lease commitments	iCoreConnect Lease Commitments as of 6/30/2021 Less than 1 year 1-3 years 3-5 years Total $ 73,980 $ 57,680 $ 0 $ 131,660
Schedule of components of lease investments	Undiscounted minimum lease commitments $ 131,660 Present value adjustment using incremental borrowing rate (30,926 ) Lease liabilities $ 100,734

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2021
SEGMENT INFORMATION (Tables)
Schedule of net sales by revenue

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Allowance for doubtful accounts	$ 76,531		$ 77,000
Goodwill	1,291,000
Accumulated deficit	(80,227,228)		(77,831,081)
Total stockholders' Deficit	2,349,546	$ 576,178	$ (628,940)	$ 205,000	$ 553,000	$ 465,000
Working capital deficit	(2,072,335)
FDIC insured limit	250,000
Operating loss	$ 186,052
Revenue , description	The Company’s secondary source of revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Eighty-four percent of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America.
Furniture and Fixtures [Member]
Estimated useful life	7 years
Computers and office equipment [Member]
Estimated useful life	3 years
Advantech [Member]
Goodwill	$ 799,000
TrinIT [Member]
Goodwill	130,000
ICD Logic [Member]
Goodwill	$ 361,000

RESTATEMENT (Details)

RESTATEMENT (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 846,039	$ 7,619
Accounts receivable, net	233,915	126,472
Prepaid expenses and other current assets	132,019	20,103
Total current assets	1,211,973	154,194
Property and equipment, net	15,090	2,405
Right of use lease asset - operating	118,182	150,477
Software development costs, net	698,349	768,907
Acquired technology, net	517,929	753,794
Customer relationships, net	1,855,664	369,524
Goodwill	1,291,109	491,376
Total long-term assets	4,496,323	2,536,483
TOTAL ASSETS	5,708,296	2,690,677
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable and accrued expenses	833,416	1,664,125
Operating lease liability, current portion	47,035	89,088
Notes payable	2,372,271	1,429,207
Deferred revenue, current portion	31,586	2,775
Total current liabilities	3,284,308	3,185,195
Operating lease liability, net of current portion	53,699	61,389
Deferred revenue, net of current portion	20,743	73,033
Total long-term liabilities	74,442	134,422
TOTAL LIABILITIES	3,358,750	3,319,617
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 151,613,399 as of June 30, 2021 and 90,081,336 as of December 31, 2020	151,613	90,081
Additional paid-in-capital	82,425,161	77,112,060
Accumulated deficit	(80,227,228)	(77,831,081)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	5,708,296	$ 2,690,677
As Restated [Member]
ASSETS
Cash and cash equivalents	846,039
Accounts receivable, net	233,915
Prepaid expenses and other current assets	132,019
Total current assets	1,211,973
Property and equipment, net	15,090
Right of use lease asset - operating	118,182
Software development costs, net	698,349
Acquired technology, net	517,929
Customer relationships, net	1,855,664
Goodwill	1,291,109
Total long-term assets	4,496,323
TOTAL ASSETS	5,708,296
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable and accrued expenses	833,416
Operating lease liability, current portion	47,035
Notes payable	2,372,271
Deferred revenue, current portion	31,586
Total current liabilities	3,284,308
Operating lease liability, net of current portion	53,699
Deferred revenue, net of current portion	20,743
Total long-term liabilities	74,442
TOTAL LIABILITIES	3,358,750
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 151,613,399 as of June 30, 2021 and 90,081,336 as of December 31, 2020	151,613
Additional paid-in-capital	82,425,161
Accumulated deficit	(80,227,228)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	2,349,546
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	5,708,296
Restatement Adjustment [Member]
ASSETS
Total current assets	0
Total long-term assets	0
TOTAL ASSETS	0
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Total current liabilities	0
Total long-term liabilities	0
TOTAL LIABILITIES	0
STOCKHOLDERS' EQUITY (DEFICIT)
Additional paid-in-capital	1,281,176
Accumulated deficit	(1,281,176)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	0
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	0
As Reported [Member]
ASSETS
Cash and cash equivalents	846,039
Accounts receivable, net	233,915
Prepaid expenses and other current assets	132,019
Total current assets	1,211,973
Property and equipment, net	15,090
Right of use lease asset - operating	118,182
Software development costs, net	698,349
Acquired technology, net	517,929
Customer relationships, net	1,855,664
Goodwill	1,291,109
Total long-term assets	4,496,323
TOTAL ASSETS	5,708,296
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable and accrued expenses	833,416
Operating lease liability, current portion	47,035
Notes payable	2,372,271
Deferred revenue, current portion	31,586
Total current liabilities	3,284,308
Operating lease liability, net of current portion	53,699
Deferred revenue, net of current portion	20,743
Total long-term liabilities	74,442
TOTAL LIABILITIES	3,358,750
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 151,613,399 as of June 30, 2021 and 90,081,336 as of December 31, 2020	151,613
Additional paid-in-capital	81,143,985
Accumulated deficit	(78,946,052)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	2,349,546
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 5,708,296

RESTATEMENT (Details 1)

RESTATEMENT (Details 1) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue	$ 981,378		$ 472,000		$ 1,685,379	$ 978,000
Cost of sales	267,728		210,000		507,761	429,000
Gross profit	713,650		262,000		1,177,618	549,000
Expenses
Selling, general and administrative	1,003,870		870,000		1,860,258	1,679,000
Depreciation and amortization	250,715		225,000		503,412	448,000
Total operating expenses	1,254,585		1,095,000		2,363,670	2,127,000
Loss from operations	(540,935)		(833,000)		(1,186,052)	(1,578,000)
Other income (expense)
Interest expense	(92,526)		(34,000)		(260,323)	(69,000)
Gain on cancellation of liabilities	331,404		0		331,404	0
Total other income (expense)	(1,042,298)		(24,000)		(1,210,095)	(59,000)
Net loss	$ (1,583,233)	$ (812,914)	$ (857,000)	$ (780,000)	(2,396,147)	$ (1,637,000)
As Restated [Member]
Revenue					1,685,379
Cost of sales					507,761
Gross profit					1,177,618
Expenses
Selling, general and administrative					1,860,258
Depreciation and amortization					503,412
Total operating expenses					2,363,670
Loss from operations					(1,186,052)
Other income (expense)
Interest expense					(260,323)
Loss on derivative liability					(1,281,176)
Gain on cancellation of liabilities					331,404
Total other income (expense)					(1,210,095)
Net loss					(2,396,147)
Restatement Adjustment [Member]
Gross profit					0
Expenses
Total operating expenses					0
Loss from operations					0
Other income (expense)
Loss on derivative liability					(1,281,176)
Total other income (expense)					(1,281,176)
Net loss					(1,281,176)
As Reported [Member]
Revenue					1,685,379
Cost of sales					507,761
Gross profit					1,177,618
Expenses
Selling, general and administrative					1,860,258
Depreciation and amortization					503,412
Total operating expenses					2,363,670
Loss from operations					(1,186,052)
Other income (expense)
Interest expense					(260,323)
Loss on derivative liability					0
Gain on cancellation of liabilities					331,404
Total other income (expense)					71,081
Net loss					$ (1,114,971)

RESTATEMENT (Details 2)

RESTATEMENT (Details 2) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITTIES
Net loss	$ (1,583,233)	$ (812,914)	$ (857,000)	$ (780,000)	$ (2,396,147)	$ (1,637,000)
Depreciation expense					1,418	5,000
Amortization expense					469,699	443,000
Change in allowance for doubtful accounts					0	0
Gain on cancellation of liabilities					(331,404)	0
Stock compensation expense					187,741	320,000
Non-cash interest expense					26,858	12,000
Accounts receivable					(107,443)	(73,000)
Fixed assets					(4,228)	0
Prepaid expenses					(111,916)	2,000
Right of use asset, net of lease liability					(17,448)	(2,000)
Accounts payable and accrued expenses					(11,174)	255,000
Deferred revenue					(23,479)	(13,000)
NET CASH USED IN OPERATING ACTIVITIES					(1,036,347)	(688,000)
INVESTING ACTIVITIES
Cash portion of consideration paid to acquire Advantech/BCS					1,850,022	375,000
Additions to capitalized software					108,752	311,000
NET CASH USED IN INVESTING ACTIVITIES					(1,958,774)	(686,000)
FINANCING ACTIVITES
Net proceeds from debt					1,795,881	416,000
Payments on debt					(875,887)	(71,000)
Proceeds from issuance of common stock					2,920,813	595,000
Proceeds from exercise of employee stock options					0	1,000
Conversion of accounts payable into common stock					(7,266)
NET CASH PROVIDED BY FINANCING ACTIVITIES					3,833,541	941,000
NET CHANGE IN CASH					838,420	(433,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		7,619		$ 445,000	7,619	445,000
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	846,039		$ 12,000		846,039	12,000
Cash paid during the period for interest					233,465	49,000
Stock issued for acquisitions					500,250	183,000
Stock issued for acquisition of technology					0	0
Stock issued for conversion of convertible notes payable					0	28,000
Stock issued for conversion of notes payable					0	0
Stock issued for conversion of accounts payable					(7,266)	$ 250,000
As Restated [Member]
CASH FLOWS FROM OPERATING ACTIVITTIES
Net loss					(2,396,147)
Depreciation expense					1,418
Amortization expense					469,699
Loss on derivative liability					(1,281,176)
Change in allowance for doubtful accounts					(331,404)
Gain on cancellation of liabilities					1,281,176
Stock compensation expense					187,741
Non-cash interest expense					26,858
Changes in assets and liabilities:					0
Accounts receivable					(107,443)
Fixed assets					(4,228)
Prepaid expenses					(111,916)
Right of use asset, net of lease liability					(17,448)
Accounts payable and accrued expenses					(11,174)
Deferred revenue					(23,479)
NET CASH USED IN OPERATING ACTIVITIES					(1,036,347)
INVESTING ACTIVITIES
Cash portion of consideration paid to acquire Advantech/BCS					1,850,022
Additions to capitalized software					(108,752)
NET CASH USED IN INVESTING ACTIVITIES					(1,958,774)
FINANCING ACTIVITES
Net proceeds from debt					1,795,881
Payments on debt					(875,887)
Proceeds from issuance of common stock					2,920,813
Proceeds from exercise of employee stock options					0
Conversion of accounts payable into common stock					(7,266)
NET CASH PROVIDED BY FINANCING ACTIVITIES					3,833,541
NET CHANGE IN CASH					838,420
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		7,619			7,619
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	846,039				846,039
Cash paid during the period for interest					233,465
Stock issued for acquisitions					500,250
Stock issued for acquisition of technology					0
Stock issued for conversion of convertible notes payable					0
Stock issued for conversion of notes payable					(7,266)
Stock issued for conversion of accounts payable					0
Restatement Adjustment [Member]
CASH FLOWS FROM OPERATING ACTIVITTIES
Net loss					(1,281,176)
Loss on derivative liability					(1,281,176)
Gain on cancellation of liabilities					1,281,176
NET CASH USED IN OPERATING ACTIVITIES					0
INVESTING ACTIVITIES
NET CASH USED IN INVESTING ACTIVITIES					0
FINANCING ACTIVITES
NET CASH PROVIDED BY FINANCING ACTIVITIES					0
NET CHANGE IN CASH					0
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		0			0
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	0				0
Cash paid during the period for interest					0
Stock issued for acquisitions					0
Stock issued for acquisition of technology					0
Stock issued for conversion of convertible notes payable					0
Stock issued for conversion of notes payable					0
Stock issued for conversion of accounts payable					0
As Reported [Member]
CASH FLOWS FROM OPERATING ACTIVITTIES
Net loss					(1,114,971)
Depreciation expense					1,418
Amortization expense					469,699
Loss on derivative liability					0
Change in allowance for doubtful accounts					(331,404)
Gain on cancellation of liabilities					0
Stock compensation expense					187,741
Non-cash interest expense					26,858
Accounts receivable					(107,443)
Fixed assets					(4,228)
Prepaid expenses					(111,916)
Right of use asset, net of lease liability					(17,448)
Accounts payable and accrued expenses					(11,174)
Deferred revenue					(23,479)
NET CASH USED IN OPERATING ACTIVITIES					(1,036,347)
INVESTING ACTIVITIES
Cash portion of consideration paid to acquire Advantech/BCS					1,850,022
Additions to capitalized software					(108,752)
NET CASH USED IN INVESTING ACTIVITIES					(1,958,774)
FINANCING ACTIVITES
Net proceeds from debt					1,795,881
Payments on debt					(875,887)
Proceeds from issuance of common stock					2,920,813
Proceeds from exercise of employee stock options					0
Conversion of accounts payable into common stock					(7,266)
NET CASH PROVIDED BY FINANCING ACTIVITIES					3,833,541
NET CHANGE IN CASH					838,420
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		$ 7,619			7,619
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	$ 846,039				846,039
Cash paid during the period for interest					233,465
Stock issued for acquisitions					500,250
Stock issued for acquisition of technology					0
Stock issued for conversion of convertible notes payable					0
Stock issued for conversion of notes payable					(7,266)
Stock issued for conversion of accounts payable					$ 0

NOTES PAYABLE AND DERIVATIVE _3

NOTES PAYABLE AND DERIVATIVE LIABILITY (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Derivative liability	$ 592,023	$ 0
Derivative Liability - Convertible Notes [Member]
Estimated number of underlying shares	2,730,000	0
Estimated market price per share	$ 0.13	$ 0
Exercise price per share	0.10
Expected volatility	291.00%	0.00%
Expected dividends	0.00%	0.00%
Expected term (in years)	2 years
Derivative liability	$ 349,488	$ 0
Derivative Liability - Warrants [Member]
Estimated number of underlying shares	9,100,000	0
Estimated market price per share	$ 0	$ 0
Exercise price per share	0.20 to $0.25
Expected volatility	291.00%	0.00%
Expected dividends	0.00%	0.00%
Expected term (in years)	10 years
Derivative liability	$ 592,023	$ 0

NOTES PAYABLE AND DERIVATIVE _4

NOTES PAYABLE AND DERIVATIVE LIABILITY (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Outstanding note payable					$ 535,021	$ 556,000
Derivative liability	$ 592,023		$ 592,023		$ 0
Loss on derivative liability	1,281,176	$ 0	$ 1,281,176	$ 0
Note payable related party, description			Subsequent to the end of fiscal 2020, the maturity on note payable to the related party was extended to a new 2-year term note payable bearing interest rate payable of 18% per annum with a maturity date of December 31, 2023.
April 2021 [Member]
Convertible promissory note	$ 150,000		$ 150,000
Debt instrument interest rate			12.00%
Proceeds from convertible promissory note			$ 150,000
Fixed conversion price	$ 0.10		$ 0.10
Note holder right description			The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time
Issuance of restricted shares	780,000		780,000
Cash payment to note holder	$ 2,600,000		$ 2,600,000
Warrant shares term			5 years
Exercise price per share description			The exercise price per share of Common Stock under this Warrant is $0.20 per share for the first 1,300,000 Warrant Shares and $0.25 for the next 1,300,000 Warrant Shares
April 2021 One [Member]
Convertible promissory note	$ 350,000		$ 350,000
Debt instrument interest rate			12.00%
Proceeds from convertible promissory note			$ 350,000
Fixed conversion price	$ 0.10		$ 0.10
Note holder right description			The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time
April 2021 Two [Member]
Convertible promissory note	$ 500,000		$ 500,000
Debt instrument interest rate			12.00%
Proceeds from convertible promissory note			$ 500,000
Fixed conversion price	$ 0.10		$ 0.10
Note holder right description			The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time
Issuance of restricted shares	788,000		788,000
Cash payment to note holder	$ 2,600,000		$ 2,600,000
Warrant shares term			5 years
Exercise price per share description			The exercise price per share of Common stock under this Warrant is $0.20 per share for the first 1,300,000 Warrant Shares and $0.25 for the next 1,300,000 Warrant Shares
April 2021 Three [Member]
Convertible promissory note	$ 250,000		$ 250,000
Debt instrument interest rate			12.00%
Proceeds from convertible promissory note			$ 250,000
Fixed conversion price	$ 0.10		$ 0.10
Note holder right description			The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time
Issuance of restricted shares	390,000		390,000
Cash payment to note holder	$ 1,300,000		$ 1,300,000
Warrant shares term			5 years
Exercise price per share description			The exercise price per share of Common stock under this Warrant is $0.20 per share for the first 650,000 Warrant Shares and $0.25 for the next 650,000 Warrant Shares
April 2021 Four [Member]
Convertible promissory note	$ 250,000		$ 250,000
Debt instrument interest rate			12.00%
Proceeds from convertible promissory note			$ 230,000
Fixed conversion price	$ 0.10		$ 0.10
Note holder right description			The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time
Issuance of restricted shares	390,000		390,000
Cash payment to note holder	$ 1,300,000		$ 1,300,000
Warrant shares term			5 years
Exercise price per share description			The exercise price per share of Common stock under this Warrant is $0.20 per share for the first 650,000 Warrant Shares and $0.25 for the next 650,000 Warrant Shares
December 31, 2018 [Member]
Debt instrument interest rate			18.00%
Issuance of notes payable to related party			$ 714,000
December 31, 2019 [Member]
Debt instrument interest rate			18.00%
Issuance of notes payable to related party			$ 556,000

COMMON STOCK (Details)

COMMON STOCK (Details)	6 Months Ended
	Jun. 30, 2021USD ($)$ / sharesshares
Options Outstanding
Number of Options/Warrants Outstanding, Beginning | shares	1,405,000
Number of Options/Warrants Outstanding, Ending | shares	1,405,000
Number of Options Outstanding, Exercisable Ending | shares	1,405,000
Weighted Average Exercise Price, Beginning | $ / shares	$ 0.24
Weighted Average Exercise Price, Exercisable | $ / shares	0.24
Weighted Average Exercise Price, Ending | $ / shares	$ 0.24
Weighted Average Remaining Contractual Term in Years, Beginning	7 years 8 months 12 days
Weighted Average Remaining Contractual Term in Years, Ending	7 years 4 months 24 days
Weighted Average Remaining Contractual Term in Years, Exercisable Ending	7 years 4 months 24 days
Aggregate Intrinsic Value, Beginning | $	$ 0
Aggregate Intrinsic Value, Ending | $	$ 0
Nonvested Options
Number of Options Nonvested, Beginning | shares	0
Number of Options Nonvested, Vested | shares	0
Number of Options Nonvested, Ending | shares	0
Weighted Average grant date Fair Value Nonvested, Beginning | $ / shares	$ 0
Weighted Average grant date Fair Value Nonvested, Vested | $ / shares	0
Weighted Average grant date Fair Value Nonvested, Ending | $ / shares	$ 0
Weighted Average Remaining Years to vest Nonvested, Begining	0 years
Weighted Average Remaining Years to vest Nonvested, Ending	0 years

COMMON STOCK (Details 1)

COMMON STOCK (Details 1)	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Shares	9,100,000
Investor One [Member]
Shares	1,300,000
Issue Date	4/19/2021
Price | $ / shares	$ 0.20
Expiration	4/19/2026
Investor Two [Member]
Shares	1,300,000
Issue Date	4/19/2021
Price | $ / shares	$ 0.25
Expiration	4/19/2026
Investor Three [Member]
Shares	1,300,000
Issue Date	4/22/2021
Price | $ / shares	$ 0.20
Expiration	4/22/2026
Investor Four [Member]
Shares	1,300,000
Issue Date	4/22/2021
Price | $ / shares	$ 0.25
Expiration	4/22/2026
Investor Five [Member]
Shares	650,000
Issue Date	4/30/2021
Price | $ / shares	$ 0.20
Expiration	4/30/2026
Investor Six [Member]
Shares	650,000
Issue Date	4/30/2021
Price | $ / shares	$ 0.25
Expiration	4/30/2026
Investor Nine [Member]
Shares	650,000
Issue Date	5/19/2021
Price | $ / shares	$ 0.20
Expiration	5/19/2026
Investor Ten [Member]
Shares	650,000
Issue Date	5/19/2021
Price | $ / shares	$ 0.25
Expiration	5/16/2026
Investor Seven [Member]
Shares	650,000
Issue Date	5/4/2021
Price | $ / shares	$ 0.20
Expiration	5/4/2026
Investor Eight [Member]
Shares	650,000
Issue Date	5/4/2021
Price | $ / shares	$ 0.25
Expiration	5/4/2026

COMMON STOCK (Details Narrative

COMMON STOCK (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Shares				9,100,000
Purchase Agreement [Member] | Investor [Member]
Line of credit descriptions	The Purchase Agreement is an equity line of credit and the Investor committed to purchase, subject to certain restrictions and conditions, up to $5.0 million worth (the “Commitment”) of the Company’s common stock over a period of 24 months
Common Stock Warrants [Member]
Exercise prices description				exercise prices of $0.20 and $0.25
Shares				9,100,000
Common stock warrants term				5 years
Executive And Employee [Member]
Common stock shares issued for cash, shares		38,500,000	38,500,000
Common stock shares issued for cash, value		$ 2,920,000	$ 2,920,000
Common stock shares issued for services, shares	7,900,000
Common stock shares issued for services, value	$ 481,923

SOFTWARE DEVELOPMENT COSTS (Det

SOFTWARE DEVELOPMENT COSTS (Details) - Software Development [Member] - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Development costs	$ 2,587,889	$ 2,479,137
Acquired technology	1,527,186	1,527,186
Less Accumulated amortization	(2,898,798)	(2,483,622)
Total Software development costs	$ 1,216,278	$ 1,522,701

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details)	Jun. 30, 2021USD ($)
Lease Commitments	$ 131,660
3-5 years [Member]
Lease Commitments	0
Less than 1 year [Member]
Lease Commitments	73,980
1-3 years [Member]
Lease Commitments	$ 57,680

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Details 1) - Lease [Member]	Jun. 30, 2021USD ($)
Undiscounted minimum lease commitments	$ 131,660
Present value adjustment using incremental borrowing rate	(30,926)
Lease liabilities	$ 100,734

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES (Details Narrative) - Lease [Member] - USD ($)	1 Months Ended		6 Months Ended
	Jul. 16, 2020	Nov. 15, 2017	Jun. 30, 2021	Jun. 30, 2020
Payments of lease liabilities				$ 44,000
Lease agreement description	The company signed a three-year lease agreement for approximately 2.100 square feet of office space located in Concord,	the Company signed a three-year lease agreement for approximately 4,100 square feet of office space located in Winter Garden
Lease costs			$ 72,880
Undiscounted minimum lease commitments			$ 131,660
January 1, 2019 [Member]
Weighted-average incremental borrowing rate			11.90%
Weighted-average remaining lease term			1 year 7 months 6 days

CONCENTRATION OF CREDIT RISK (D

CONCENTRATION OF CREDIT RISK (Details Narrative)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Total revenue percentage	10.00%	10.00%
Description of concentration of credit risk	Overall, the company grew its accounts receivable approximately ending balance 29% for the 6 months ending June 30, 2021 compared to the 6 months ending June 30, 2020, compared to an over 71% growth in sales for the same period. Day’s sales outstanding was less than 30 days as of June 30, 2021
Customers [Member]
Percentage of accounts receivable	20.00%
Customers Two [Member]
Percentage of accounts receivable	11.00%
Customers Three [Member]
Percentage of accounts receivable	11.00%

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Total [Member]
Total revenue	$ 1,685,379	$ 977,863
Revenue percentages	100.00%	100.00%
Revenue change percentage		72.00%
Revenue Segment [Member]
Revenues:
Subscription software and services	$ 1,464,629	$ 778,245
Subscription software and services, percentage	87.00%	80.00%
Subscription software and services, change percentages		88.00%
Professional services and other	$ 220,750	$ 199,619
Professional services and other, percentage	13.00%	20.00%
Professional services and other, change percentages		11.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
RELATED PARTY TRANSACTIONS
Interest payment related Party	$ 45,872	$ 44,339

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	Jun. 30, 2021USD ($)shares
September 1, 2021 [Member]
Issuance of notes payable | $	$ 1,500,000
Warrants issued | shares	1,500,000
Inducement shares issued | shares	1,000,000
Issuance of commn stock | shares	500,000
August 24, 2021 [Member]
Lender obgilation | $	$ 863,274
Repayment of tendering payment | $	$ 28,578